ClouDr Group (HKSE:09955) Accounts Payable & Accrued Expense : HK$632 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Accounts Payable & Accrued Expense?

ClouDr Group's quarterly accounts payable & accrued expense declined from Dec. 2022 (HK$625 Mil) to Jun. 2023 (HK$613 Mil) but then increased from Jun. 2023 (HK$613 Mil) to Dec. 2023 (HK$632 Mil).

ClouDr Group's annual accounts payable & accrued expense increased from Dec. 2021 (HK$619 Mil) to Dec. 2022 (HK$625 Mil) and increased from Dec. 2022 (HK$625 Mil) to Dec. 2023 (HK$632 Mil).

ClouDr Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for ClouDr Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Accounts Payable & Accrued Expense Chart

ClouDr Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

216.18

292.00

619.45

624.97

632.42

ClouDr Group Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			619.45	684.37	624.97	613.25	632.42

ClouDr Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ClouDr Group (HKSE:09955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

H3L:Germany

Address

No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.cloudr.cn

ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

Executives

Trident Trust Company (hk) Limited	2301 Trustee
Data Vantage Development Limited	2201 Interest of corporation controlled by you
Kuang Ming	2201 Interest of corporation controlled by you
Prime Forest Assets Limited	2101 Beneficial owner
Shang Hai Qi Ji Ke Ji He Huo Qi Ye You Xian He Huo
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Zhao Yin Guo Ji Jin Rong You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Ho Chi Sing	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.
Zhou Quan	2201 Interest of corporation controlled by you
Idg China Venture Capital Fund Gp Iv Associates Ltd.	2201 Interest of corporation controlled by you
Haoyuan Health Limited	2101 Beneficial owner
Yass Jeffrey Steven

ClouDr Group (HKSE:09955) Headlines

No Headlines